Analyst Price Targets — ELAN
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| May 15, 2026 12:27 pm | — | Morgan Stanley | $23.00 | $20.92 | TheFly | Elanco price target lowered to $23 from $24 at Morgan Stanley |
| February 25, 2026 1:33 pm | Steve Dechert | KeyBanc | $29.00 | $27.13 | StreetInsider | 'Elanco Animal Health (ELAN) set up well for beats and raises'; PT Raised to $29 at KeyBanc |
| February 24, 2026 7:50 pm | Daniel Clark | Leerink Partners | $30.00 | $26.37 | TheFly | Elanco price target raised to $30 from $26 at Leerink |
| January 29, 2026 2:33 pm | — | UBS | $30.00 | $24.17 | TheFly | Elanco price target raised to $30 from $27 at UBS |
| January 22, 2026 8:42 am | David Westenberg | Piper Sandler | $30.00 | $24.30 | StreetInsider | Piper Sandler Upgrades Elanco Animal Health (ELAN) to Overweight |
| December 18, 2025 12:55 pm | — | Morgan Stanley | $22.00 | $22.08 | TheFly | Elanco price target raised to $22 from $18 at Morgan Stanley |
| December 8, 2025 9:26 pm | — | Barclays | $30.00 | $21.69 | TheFly | Elanco initiated with an Overweight at Barclays |
| November 20, 2025 9:21 pm | — | KeyBanc | $27.00 | $21.46 | TheFly | Elanco initiated with an Overweight at KeyBanc |
| November 19, 2025 1:20 pm | — | Argus Research | $25.00 | $21.46 | TheFly | Elanco upgraded to Buy from Hold at Argus |
| November 5, 2025 6:03 pm | — | Stifel Nicolaus | $27.00 | $21.91 | TheFly | Elanco price target raised to $27 from $23 at Stifel |
Latest News for ELAN
Allspring Global Investments Holdings LLC acquired a new position in Elanco Animal Health Incorporated (NYSE: ELAN) in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 2,871,561 shares of the company's stock, valued at approximately $66,390,000. Allspring Global Investments Holdings LLC owned 0.58%
Elanco Animal Health (ELAN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
INDIANAPOLIS, July 8, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its second quarter 2026 financial results on Wednesday, August 5, 2026. Elanco will also conduct a conference call on that day with the investment community and media to further detail the company's performance.
Investors need to pay close attention to ELAN stock based on the movements in the options market lately.
New corporate venture capital platform will invest to advance therapeutics, technologies and One Health solutions INDIANAPOLIS, June 18, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced plans to establish Elanco Ventures, a dedicated corporate venture capital (CVC) platform designed to support, invest and advance innovation in animal health. To be backed by a $25 million multi-year…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.